FDA.reportPublic FDA data

betamethasone dipropionate 0.643 MG/ML

RxCUI
1716092
RxNorm name
betamethasone dipropionate 0.643 MG/ML
Term type
SCDC
Status
Active
Updated
2026-10-21 00:29:14

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112015
Active start
112015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
0.643 MG / 1 MLbetamethasone

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
betamethasone1514

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbetamethasone dipropionate 0.643 MG/ML1NAMES
RxNorm Namebetamethasone dipropionate 0.643 MG/ML1NAMES
TTYSCDC1ATTRIBUTES
RxCUI17160921CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4betamethasone
ATCS03BACorticosteroidsATC1-4betamethasone
ATCS02BACorticosteroidsATC1-4betamethasone
ATCR01ADCorticosteroidsATC1-4betamethasone
ATCA07EACorticosteroids acting locallyATC1-4betamethasone
ATCS01BACorticosteroids, plainATC1-4betamethasone
ATCD07ACCorticosteroids, potent (group III)ATC1-4betamethasone
ATCD07XCCorticosteroids, potent, other combinationsATC1-4betamethasone
ATCS01CBCorticosteroids/antiinfectives/mydriatics in combinationATC1-4betamethasone
ATCR03BAGlucocorticoidsATC1-4betamethasone
ATCH02ABGlucocorticoidsATC1-4betamethasone
FDASPLN0000175576CorticosteroidEPChas_epcbetamethasone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moabetamethasone
MEDRTD001623BetamethasoneCHEMhas_ingredientbetamethasone dipropionate
MEDRTD001623BetamethasoneCHEMhas_ingredientbetamethasone
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatbetamethasone dipropionate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatbetamethasone
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatbetamethasone dipropionate
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatbetamethasone
MEDRTD004342Drug HypersensitivityDISEASEci_withbetamethasone
MEDRTD004342Drug HypersensitivityDISEASEci_withbetamethasone dipropionate
MEDRTD005148Facial DermatosesDISEASEmay_treatbetamethasone
MEDRTD005148Facial DermatosesDISEASEmay_treatbetamethasone dipropionate
MEDRTD005533Foot DermatosesDISEASEmay_treatbetamethasone
MEDRTD005533Foot DermatosesDISEASEmay_treatbetamethasone dipropionate
MEDRTD006229Hand DermatosesDISEASEmay_treatbetamethasone
MEDRTD006229Hand DermatosesDISEASEmay_treatbetamethasone dipropionate
MEDRTD007249InflammationDISEASEmay_treatbetamethasone dipropionate
MEDRTD007249InflammationDISEASEmay_treatbetamethasone
MEDRTD007868Leg DermatosesDISEASEmay_treatbetamethasone dipropionate
MEDRTD007868Leg DermatosesDISEASEmay_treatbetamethasone
MEDRTD009181MycosesDISEASEci_withbetamethasone dipropionate
MEDRTD009181MycosesDISEASEci_withbetamethasone
MEDRTD011538Pruritus AniDISEASEmay_treatbetamethasone dipropionate
MEDRTD011538Pruritus AniDISEASEmay_treatbetamethasone
MEDRTD011565PsoriasisDISEASEmay_treatbetamethasone dipropionate
MEDRTD011565PsoriasisDISEASEmay_treatbetamethasone
MEDRTD016553Purpura, Thrombocytopenic, IdiopathicDISEASEci_withbetamethasone dipropionate
MEDRTD016553Purpura, Thrombocytopenic, IdiopathicDISEASEci_withbetamethasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatbetamethasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatbetamethasone dipropionate
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moabetamethasone dipropionate
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moabetamethasone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moabetamethasone dipropionate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moabetamethasone
MEDRTN0000008297Antipruritic ActivityPEhas_pebetamethasone dipropionate
MEDRTN0000008297Antipruritic ActivityPEhas_pebetamethasone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pebetamethasone dipropionate
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pebetamethasone
MEDRTN0000009928Decreased Cellular MigrationPEhas_pebetamethasone dipropionate
MEDRTN0000009928Decreased Cellular MigrationPEhas_pebetamethasone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pebetamethasone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pebetamethasone dipropionate
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pebetamethasone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pebetamethasone dipropionate
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pebetamethasone
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pebetamethasone dipropionate
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pebetamethasone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pebetamethasone dipropionate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pebetamethasone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pebetamethasone dipropionate
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pebetamethasone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pebetamethasone dipropionate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pebetamethasone dipropionate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pebetamethasone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESIN_EXPRESSED_FLAGP
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH0.643 MG/ML